Heat Biologics

(NASDAQ: HTBX)
Healthcare  |  Biotechnology
0.44 -0.0071 -1.57%
Stock Price | Dec. 13, 2019, 4 p.m.
0 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 0.451
52 Week Low: 0.35
52 Week High: 1.8
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies which activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells which secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector.

Read more Read less

Recently Viewed Tickers

Free Stock Watchlist 06/23/2016

3 years ago

Premium Stock Watchlist 04/27/2016

3 years ago

Premium Stock Watchlist 04/26/2016

3 years ago